No CrossRef data available.
Article contents
Unlocking the ocean's potential: advancing marine natural products for cancer therapy with a focus on glioblastoma multiforme
Published online by Cambridge University Press: 30 September 2025
Abstract
Cancer, a multifactorial and heterogeneous disease, poses a significant global health challenge. Despite current treatments such as surgery, radiotherapy, and chemotherapy, tumour recurrence and treatment side effects are common. These pitfalls necessitate a dire need for alternative therapeutic strategies with minimal side effects. This necessity has broadened the horizons of drug discovery into the marine domain, an exciting frontier for novel therapeutic agents. The marine ecosystem serves as a hub of diverse chemical groups with potential anti-cancer properties. Few marine-derived drugs are approved for cancer, and preliminary studies show that marine lead compounds can inhibit cancer cell growth and induce apoptosis. In this context, this review encapsulates an overview of ‘the current state of marine biodiscovery’. It explores the ‘potential of marine natural products in combating cancer’ with a particular focus on glioblastoma multiforme as a case study. Additionally, it discusses the ‘key strategies for advancing marine-derived anti-cancer compounds from the research stage to clinical use’. By tapping into the vast, unlocking the hidden treasures of the ocean, marine natural compounds could offer a hopeful perspective in the fight against cancer.
Keywords
Information
- Type
- Review
- Information
- Copyright
- Copyright © The Author(s), 2025. Published by Cambridge University Press on behalf of Marine Biological Association of the United Kingdom
References
Aguiar-Pulido, V, Huang, W, Suarez-Ulloa, V, Cickovski, T, Mathee, K and Narasimhan, G (2016) Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis. Evolutionary Bioinformatics Online 12, 5–16.Google ScholarPubMed
Ahmed, SA, Mendonca, P, Elhag, R and Soliman, KFA (2022) Anticancer effects of fucoxanthin through cell cycle arrest, apoptosis induction, angiogenesis inhibition, and autophagy modulation. International Journal of Molecular Sciences 23, 16091.10.3390/ijms232416091CrossRefGoogle ScholarPubMed
Alves, A, Costa, P, Pinto, M, Ferreira, D and Correia-da-Silva, M (2021) Small molecules of marine origin as potential anti-glioma agents. Molecules 26, 2707.10.3390/molecules26092707CrossRefGoogle ScholarPubMed
Alves, C, Silva, J, Pinteus, S, Gaspar, H, Alpoim, MC, Botana, LM and Pedrosa, R (2018) From marine origin to therapeutics: the antitumor potential of marine algae-derived compounds. Frontiers in Pharmacology 9, 777.10.3389/fphar.2018.00777CrossRefGoogle ScholarPubMed
Anand, U, Dey, A, Chandel, AKS, Sanyal, R, Mishra, A, Pandey, DK, De Falco, V, Upadhyay, A, Kandimalla, R, Chaudhary, A, Dhanjal, JK, Dewanjee, S, Vallamkondu, J and Pérez de la Lastra, JM (2023) Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases 10, 1367–1401.10.1016/j.gendis.2022.02.007CrossRefGoogle ScholarPubMed
Atanasov, AG, Zotchev, SB, Dirsch, VM and Supuran, CT (2021) Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery 20, 200–216.10.1038/s41573-020-00114-zCrossRefGoogle ScholarPubMed
Baghban, R, Roshangar, L, Jahanban-Esfahlan, R, Seidi, K, Ebrahimi-Kalan, A, Jaymand, M, Kolahian, S, Javaheri, T and Zare, P (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling 18, 1–19.10.1186/s12964-020-0530-4CrossRefGoogle ScholarPubMed
Banday, AH, ul Azha, N, Farooq, R, Sheikh, SA, Ganie, MA, Parray, MN, Mushtaq, H, Hameed, I and Lone, MA (2024) Exploring the potential of marine natural products in drug development: a comprehensive review. Phytochemistry Letters 59, 124–135.10.1016/j.phytol.2024.01.001CrossRefGoogle Scholar
Bartik, K, Braekman, J-C, Daloze, D, Stoller, C, Huysecom, J, Vandevyver, G and Ottinger, R (1987) Topsentins, new toxic bis-indole alkaloids from the marine sponge Topsentia genitrix. Canadian Journal of Chemistry 65, 2118–2121.10.1139/v87-352CrossRefGoogle Scholar
Batool, F, Delpy, E, Zal, F, Leize-Zal, E and Huck, O (2021) Therapeutic potential of hemoglobin derived from the marine worm Arenicola marina (M101): a literature review of a breakthrough innovation. Marine Drugs 19, 376.10.3390/md19070376CrossRefGoogle ScholarPubMed
Besednova, NN, Andryukov, BG, Zaporozhets, TS, Kuznetsova, TA, Kryzhanovsky, SP, Ermakova, SP, Galkina, IV and Shchelkanov, MYU (2022) Molecular targets of brown algae phlorotannins for the therapy of inflammatory processes of various origins. Marine Drugs 20, 243.10.3390/md20040243CrossRefGoogle Scholar
Bi, D, Yang, X, Yao, L, Hu, Z, Li, H, Xu, X and Lu, J (2022) Potential food and nutraceutical applications of alginate: a review. Marine Drugs 20, 564.10.3390/md20090564CrossRefGoogle ScholarPubMed
Biegelmeyer, R, Schröder, R, Rambo, D, Dresch, R, Carraro, J, Mothes, B, Moreira, JC, Junior, M and Henriques, A (2015) Sphingosines derived from marine sponge as potential multi-target drug related to disorders in cancer development. Marine Drugs 13, 5552–5563.10.3390/md13095552CrossRefGoogle ScholarPubMed
Biswas, I, Precilla, SD, Kuduvalli, SS, B, K, S, R and A, TS (2024) Ultrastructural and immunohistochemical insights on the anti-glioma effects of a dual-drug cocktail in an in vivo experimental model. Journal of Chemotherapy 36, 1–14.10.1080/1120009X.2024.2302741CrossRefGoogle Scholar
Biswas, I, Precilla, DS, Kuduvalli, SS, Ramachandran, MA, Akshaya, S, Raman, V, Prabhu, D and Anitha, TS (2023) Unveiling the anti-glioma potential of a marine derivative, fucoidan: its synergistic cytotoxicity with temozolomide – an in vitro and in silico experimental study. 3 Biotech 13, 397.10.1007/s13205-023-03814-6CrossRefGoogle Scholar
Blasiak, R, Wynberg, R, Grorud-Colvert, K, Thambisetty, S, Bandarra, NM, Canário, AVM, da Silva, J, Duarte, CM, Jaspars, M, Rogers, A, Sink, K and Wabnitz, CCC (2020) The ocean genome and future prospects for conservation and equity. Nature Sustainability 3, 588–596.10.1038/s41893-020-0522-9CrossRefGoogle Scholar
Bo, G (2000) Giuseppe Brotzu and the discovery of cephalosporins. Clinical Microbiology and Infection 6, 6–9.10.1111/j.1469-0691.2000.tb02032.xCrossRefGoogle ScholarPubMed
Borbone, N, De Marino, S, Iorizzi, M, Zollo, F, Debitus, C, Esposito, G and Iuvone, T (2002) Minor steroidal alkaloids from the marine sponge Corticium sp. Journal of Natural Products 65, 1206–1209.10.1021/np020027rCrossRefGoogle ScholarPubMed
Burja, AM, Abou-Mansour, E, Banaigs, B, Payri, C, Burgess, JG and Wright, PC (2002) Culture of the marine cyanobacterium, Lyngbya majuscula (Oscillatoriaceae), for bioprocess intensified production of cyclic and linear lipopeptides. Journal of Microbiological Methods 48, 207–219.10.1016/S0167-7012(01)00324-4CrossRefGoogle ScholarPubMed
Caplan, SL, Zheng, B, Dawson-Scully, K, White, CA and West, LM (2016) Pseudopterosin A: protection of synaptic function and potential as a neuromodulatory agent. Marine Drugs 14, 55.10.3390/md14030055CrossRefGoogle ScholarPubMed
Cappello, E and Nieri, P (2021) From life in the sea to the clinic: the marine drugs approved and under clinical trial. Life 11, 1390.10.3390/life11121390CrossRefGoogle Scholar
Carter, NJ and Keam, SJ (2007) Trabectedin: a review of its use in the management of soft tissue sarcoma and ovarian cancer. Drugs 67, 2257–2276.10.2165/00003495-200767150-00009CrossRefGoogle ScholarPubMed
Challita-Eid, PM, Satpayev, D, Yang, P, An, Z, Morrison, K, Shostak, Y, Raitano, A, Nadell, R, Liu, W, Lortie, DR, Capo, L, Verlinsky, A, Leavitt, M, Malik, F, Aviña, H, Guevara, CI, Dinh, N, Karki, S, Anand, BS, Pereira, DS, Joseph, IBJ, Doñate, F, Morrison, K and Stover, DR (2016) Enfortumab vedotin antibody–drug conjugate targeting nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models. Cancer Research 76, 3003–3013.10.1158/0008-5472.CAN-15-1313CrossRefGoogle ScholarPubMed
Chang, Z, Sitachitta, N, Rossi, JV, Roberts, MA, Flatt, PM, Jia, J, Sherman, DH and Gerwick, WH (2004) Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula. Journal of Natural Products 67, 1356–1367.10.1021/np0499261CrossRefGoogle ScholarPubMed
Chen, M, Chai, W, Song, T, Ma, M, Yuan, X and Zhang, Z (2018) Anti-glioma natural products downregulating tumor glycolytic enzymes from marine actinomycete Streptomyces sp. ZZ406. Scientific Reports 8, 72.10.1038/s41598-017-18484-7CrossRefGoogle ScholarPubMed
Cheng, S-Y, Chen, N-F, Kuo, H-M, Yang, S-N, Sung, C-S, Sung, P-J, Wen, Z-H and Chen, W-F (2018) Prodigiosin stimulates endoplasmic reticulum stress and induces autophagic cell death in glioblastoma cells. Apoptosis 23, 314–328.10.1007/s10495-018-1456-9CrossRefGoogle ScholarPubMed
Cheng, S-Y, Chen, N-F, Lin, P-Y, Su, J-H, Chen, B-H, Kuo, H-M, Sung, C-S, Sung, P-J, Wen, Z-H and Chen, W-F (2019) Anti-invasion and antiangiogenic effects of stellettin B through inhibition of the Akt/girdin signaling pathway and VEGF in glioblastoma cells. Cancers 11, 220.10.3390/cancers11020220CrossRefGoogle ScholarPubMed
Cho, M, Park, G-M, Kim, S-N, Amna, T, Lee, S and Shin, W-S (2014) Glioblastoma-specific anticancer activity of pheophorbide a from the edible red seaweed Grateloupia elliptica. Journal of Microbiology and Biotechnology 24, 346–353.10.4014/jmb.1308.08090CrossRefGoogle ScholarPubMed
Cleary, DFR, Polónia, ARM, Becking, LE, de Voogd, NJ, Purwanto, GH and Gomes, NCM (2018) Compositional analysis of bacterial communities in seawater, sediment, and sponges in the Misool coral reef system, Indonesia. Marine Biodiversity 48, 1889–1901.10.1007/s12526-017-0697-0CrossRefGoogle Scholar
Connors, JM, Jurczak, W, Straus, DJ, Ansell, SM, Kim, WS, Gallamini, A, Younes, A, Alekseev, S, Illés, Á, Picardi, M, Lech-Maranda, E, Oki, Y, Feldman, T, Smolewski, P, Savage, KJ, Bartlett, NL, Walewski, J, Chen, R, Ramchandren, R, Zinzani, PL, Cunningham, D, Rosta, A, Josephson, NC, Song, E, Sachs, J, Liu, R, Jolin, HA, Huebner, D and Radford, J (2018) Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma. New England Journal of Medicine 378, 331–344.10.1056/NEJMoa1708984CrossRefGoogle ScholarPubMed
Corley, DG, Herb, R, Moore, RE, Scheuer, PJ and Paul, VJ (1988) Laulimalides. New potent cytotoxic macrolides from a marine sponge and a nudibranch predator. The Journal of Organic Chemistry 53, 3644–3646.10.1021/jo00250a053CrossRefGoogle Scholar
Counts, JA, Zeldes, BM, Lee, LL, Straub, CT, Adams, MWW and Kelly, RM (2017) Physiological, metabolic and biotechnological features of extremely thermophilic microorganisms. Wiley Interdisciplinary Reviews. Systems Biology and Medicine 9, 10.1002/wsbm.1377.Google ScholarPubMed
Daisy Precilla, S, Kuduvalli, SS, Biswas, I, Bhavani, K, Pillai, AB, Thomas, JM and Anitha, TS (2023) Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma-induced xenograft model by modulating WNT/β-catenin signaling. Fundamental & Clinical Pharmacology 37, 1179–1197.10.1111/fcp.12932CrossRefGoogle Scholar
Deighton, RF, McGregor, R, Kemp, J, McCulloch, J and Whittle, IR (2010) Glioma pathophysiology: insights emerging from proteomics. Brain Pathology 20, 691–703.10.1111/j.1750-3639.2010.00376.xCrossRefGoogle ScholarPubMed
Deng, C, Pan, B and O'Connor, OA (2013) Brentuximab vedotin. Clinical Cancer Research 19, 22–27.10.1158/1078-0432.CCR-12-0290CrossRefGoogle ScholarPubMed
De Souza, MVN (2004) (+)-Discodermolide: a marine natural product against cancer. The Scientific World Journal 4, 415–436.10.1100/tsw.2004.96CrossRefGoogle ScholarPubMed
Dias, DM, Coombes, SR, Benstead, D, Whittaker, DTE, Ray, A and Xu, J (2023) Advances in the specificity of mass spectrometry and nuclear magnetic resonance spectroscopy based structural characterisation methods for synthetic oligonucleotides. Journal of Pharmaceutical Sciences 112, 2524–2531.10.1016/j.xphs.2023.04.013CrossRefGoogle ScholarPubMed
Di Francia, R, Crisci, S, De Monaco, A, Cafiero, C, Re, A, Iaccarino, G, De Filippi, R, Frigeri, F, Corazzelli, G, Micera, A and Pinto, A (2021) Response and toxicity to cytarabine therapy in leukemia and lymphoma: from dose puzzle to pharmacogenomic biomarkers. Cancers 13, 966.10.3390/cancers13050966CrossRefGoogle ScholarPubMed
D'Incalci, M, Badri, N, Galmarini, CM and Allavena, P (2014) Trabectedin, a drug acting on both cancer cells and the tumour microenvironment. British Journal of Cancer 111, 646–650.10.1038/bjc.2014.149CrossRefGoogle ScholarPubMed
Dithmer, M, Fuchs, S, Shi, Y, Schmidt, H, Richert, E, Roider, J and Klettner, A (2014) Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis in vitro. PLoS ONE 9, e89150.10.1371/journal.pone.0089150CrossRefGoogle ScholarPubMed
Elmallah, MIY and Micheau, O (2015) Marine drugs regulating apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Marine Drugs 13, 6884–6909.10.3390/md13116884CrossRefGoogle ScholarPubMed
Erba, E, Bergamaschi, D, Ronzoni, S, Faretta, M, Taverna, S, Bonfanti, M, Catapano, CV, Faircloth, G, Jimeno, J and D'Incalci, M (1999) Mode of action of thiocoraline, a natural marine compound with anti-tumour activity. British Journal of Cancer 80, 971–980.10.1038/sj.bjc.6690451CrossRefGoogle ScholarPubMed
Facompré, M, Tardy, C, Bal-Mahieu, C, Colson, P, Perez, C, Manzanares, I, Cuevas, C and Bailly, C (2003) Lamellarin D: a novel potent inhibitor of topoisomerase I. Cancer Research 63, 7392–7399.Google ScholarPubMed
Fakhri, S, Abdian, S, Moradi, SZ, Delgadillo, BE, Fimognari, C and Bishayee, A (2022) Marine compounds, mitochondria, and malignancy: a therapeutic nexus. Marine Drugs 20, 625.10.3390/md20100625CrossRefGoogle ScholarPubMed
Fang, S, Bi, S, Li, Y, Tian, S, Xu, H, Fu, L, Wang, S, Tang, Y and Qiu, P (2023) Design, synthesis and anti-tumor evaluation of plinabulin derivatives as potential agents targeting β-tubulin. Bioorganic & Medicinal Chemistry Letters 91, 129370.10.1016/j.bmcl.2023.129370CrossRefGoogle ScholarPubMed
Fontaine, B, Perrard, A and Bouchet, P (2012) 21 years of shelf life between discovery and description of new species. Current Biology: CB 22, R943–R944.10.1016/j.cub.2012.10.029CrossRefGoogle ScholarPubMed
Francisco, JA, Cerveny, CG, Meyer, DL, Mixan, BJ, Klussman, K, Chace, DF, Rejniak, SX, Gordon, KA, DeBlanc, R, Toki, BE, Law, C-L, Doronina, SO, Siegall, CB, Senter, PD and Wahl, AF (2003) cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 102, 1458–1465.10.1182/blood-2003-01-0039CrossRefGoogle ScholarPubMed
Funahashi, Y, Okamoto, K, Adachi, Y, Semba, T, Uesugi, M, Ozawa, Y, Tohyama, O, Uehara, T, Kimura, T, Watanabe, H, Asano, M, Kawano, S, Tizon, X, McCracken, PJ, Matsui, J, Aoshima, K, Nomoto, K and Oda, Y (2014) Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models. Cancer Science 105, 1334–1342.10.1111/cas.12488CrossRefGoogle ScholarPubMed
Gao, G, Wang, Y, Hua, H, Li, D and Tang, C (2021) Marine antitumor peptide dolastatin 10: biological activity, structural modification and synthetic chemistry. Marine Drugs 19, 363.10.3390/md19070363CrossRefGoogle ScholarPubMed
García-Poza, S, Leandro, A, Cotas, C, Cotas, J, Marques, JC, Pereira, L and Gonçalves, AMM (2020) The evolution road of seaweed aquaculture: cultivation technologies and the Industry 4.0. International Journal of Environmental Research and Public Health 17, 6528.10.3390/ijerph17186528CrossRefGoogle ScholarPubMed
Gong, A, Guo, P, Gong, L and Liang, H (2016) Aplysin suppresses the invasion of glioma cells by targeting Akt pathway. International Journal of Clinical and Experimental Medicine 9, 8062–8068.Google Scholar
Gurunathan, R, Rathinam, AJ, Hwang, J-S and Dahms, H-U (2021) Shallow hydrothermal vent bacteria and their secondary metabolites with a particular focus on bacillus. Marine Drugs 19, 681.10.3390/md19120681CrossRefGoogle ScholarPubMed
Hainan Normal University (2017 a) Mangrove Fungus Derived Chloroanthraquinone Compound and Application of Mangrove Fungus Derived Chloroanthraquinone Compound Serving as Antibacterial Agent. Hainan Normal University. https://patents.google.com/patent/CN106631803B/zhGoogle Scholar
Hainan Normal University (2017 b) Isocoumarin Compound with Anti-Vibrio Activity Function and Crystal Thereof. Hainan Normal University. https://patents.google.com/patent/CN106432169A/enGoogle Scholar
Hainan Normal University (2018) A Kind of Indoles Diterpene-Kind Compound of Mangrove Xylocarpus granatum Originated from Fungus and Preparation Method and Application. Hainan Normal University. https://patents.google.com/patent/CN107827805A/enGoogle Scholar
Hamann, MT (2004) Technology evaluation: kahalalide F, PharmaMar. Current Opinion in Molecular Therapeutics 6, 657–665.Google ScholarPubMed
Hamann, MT, Otto, CS, Scheuer, PJ and Dunbar, DC (1996) Kahalalides: bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp. The Journal of Organic Chemistry 61, 6594–6600.10.1021/jo960877+CrossRefGoogle ScholarPubMed
Harrington, M (2015) Blue-bloods of the sea. Lab Animal 44, 83–83.10.1038/laban.715CrossRefGoogle ScholarPubMed
Huyck, TK, Gradishar, W, Manuguid, F and Kirkpatrick, P (2011) Eribulin mesylate. Nature Reviews Drug Discovery 10, 173–174.10.1038/nrd3389CrossRefGoogle ScholarPubMed
Institute of Microbiology of CAS (2013) Polycyclic Polyketone Compounds from Marine Verrucosispora sp., and Preparation Method and Application Thereof. Institute of Microbiology of CAS. https://patents.google.com/patent/CN103319496A/enGoogle Scholar
Iwamaru, A, Iwado, E, Kondo, S, Newman, RA, Vera, B, Rodríguez, AD and Kondo, Y (2007) Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Molecular Cancer Therapeutics 6, 184–192.10.1158/1535-7163.MCT-06-0422CrossRefGoogle ScholarPubMed
Jeong, G-J, Khan, S, Tabassum, N, Khan, F and Kim, Y-M (2022) Marine-bioinspired nanoparticles as potential drugs for multiple biological roles. Marine Drugs 20, 527.10.3390/md20080527CrossRefGoogle ScholarPubMed
Jiang, M, Li, Q and Xu, B (2024) Spotlight on ideal target antigens and resistance in antibody–drug conjugates: strategies for competitive advancement. Drug Resistance Updates 75, 101086.10.1016/j.drup.2024.101086CrossRefGoogle ScholarPubMed
Jimenez, PC, Wilke, DV, Branco, PC, Bauermeister, A, Rezende-Teixeira, P, Gaudêncio, SP and Costa-Lotufo, LV (2020) Enriching cancer pharmacology with drugs of marine origin. British Journal of Pharmacology 177, 3–27.10.1111/bph.14876CrossRefGoogle ScholarPubMed
Karthikeyan, A, Joseph, A and Nair, BG (2022) Promising bioactive compounds from the marine environment and their potential effects on various diseases. Journal of Genetic Engineering & Biotechnology 20, 14.10.1186/s43141-021-00290-4CrossRefGoogle ScholarPubMed
Kepp, O, Zitvogel, L and Kroemer, G (2020) Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer. Oncoimmunology 9, 1795995.10.1080/2162402X.2020.1795995CrossRefGoogle ScholarPubMed
Khotimchenko, R, Bryukhovetskiy, I, Khotimchenko, M and Khotimchenko, Y (2021) Bioactive compounds with antiglioma activity from marine species. Biomedicines 9, 886.10.3390/biomedicines9080886CrossRefGoogle ScholarPubMed
Kim, HJ, Kim, JH, Chie, EK, Da Young, P, Kim, IA and Kim, IH (2012) DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiation Oncology 7, 39.10.1186/1748-717X-7-39CrossRefGoogle ScholarPubMed
Kirschbaum, C, Young, RSE, Greis, K, Menzel, JP, Gewinner, S, Schöllkopf, W, Meijer, G, von Helden, G, Causon, T, Narreddula, VR, Poad, BLJ, Blanksby, SJ and Pagel, K (2023) Establishing carbon–carbon double bond position and configuration in unsaturated fatty acids by gas-phase infrared spectroscopy. Chemical Science 14, 2518–2527.10.1039/D2SC06487ACrossRefGoogle ScholarPubMed
Kong, D, Aoki, S, Sowa, Y, Sakai, T and Kobayashi, M (2008) Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells. Marine Drugs 6, 480–488.Google ScholarPubMed
Kowalczyk, JJ, Schiller, SER, Spyvee, M, Yang, H, Seletsky, BM, Shaffer, CJ, Marceau, V, Yao, Y, Kuznetsov, G, Tendyke, K, Liu, D, Rowell, C, Littlefield, BA and Suh, EM (2005) Synthetic analogs of the marine natural product hemiasterlin: optimization and discovery of E7974, a novel and potent antitumor agent. Cancer Research 65, 282.Google Scholar
Kuo, T-J, Jean, Y-H, Shih, P-C, Cheng, S-Y, Kuo, H-M, Lee, Y-T, Lai, Y-C, Tseng, C-C, Chen, W-F and Wen, Z-H (2022) Stellettin B-induced oral cancer cell death via endoplasmic Reticulum stress–mitochondrial apoptotic and autophagic signaling pathway. International Journal of Molecular Sciences 23, 8813.10.3390/ijms23158813CrossRefGoogle ScholarPubMed
La Manna, S, Di Natale, C, Florio, D and Marasco, D (2018) Peptides as therapeutic agents for inflammatory-related diseases. International Journal of Molecular Sciences 19, 2714.10.3390/ijms19092714CrossRefGoogle ScholarPubMed
Lan, Z, Li, X and Zhang, X (2024) Glioblastoma: an update in pathology, molecular mechanisms and biomarkers. International Journal of Molecular Sciences 25, 3040.10.3390/ijms25053040CrossRefGoogle ScholarPubMed
Leiman, DA, Riff, BP, Morgan, S, Metz, DC, Falk, GW, French, B, Umscheid, CA and Lewis, JD (2017) Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Diseases of the Esophagus 30, 1–9.10.1093/dote/dow020CrossRefGoogle ScholarPubMed
Leisch, M, Egle, A and Greil, R (2019) Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma. Future Oncology 15, 109–120.10.2217/fon-2018-0492CrossRefGoogle ScholarPubMed
Le Tourneau, C, Raymond, E and Faivre, S (2007) Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison. Current Pharmaceutical Design 13, 3427–3439.10.2174/138161207782360555CrossRefGoogle ScholarPubMed
Li, X, Dai, J, Tang, Y, Li, L and Jin, G (2017) Quantitative proteomic profiling of tachyplesin I targets in U251 gliomaspheres. Marine Drugs 15, 20.10.3390/md15010020CrossRefGoogle ScholarPubMed
Liang, Y, Xie, X, Chen, L, Yan, S, Ye, X, Anjum, K, Huang, H, Lian, X and Zhang, Z (2016) Bioactive polycyclic quinones from marine Streptomyces sp. 182SMLY. Marine Drugs 14, 10.10.3390/md14010010CrossRefGoogle ScholarPubMed
Lindequist, U (2016) Marine-derived pharmaceuticals – challenges and opportunities. Biomolecules & Therapeutics 24, 561–571.10.4062/biomolther.2016.181CrossRefGoogle ScholarPubMed
Liu, M, El-Hossary, EM, Oelschlaeger, TA, Donia, MS, Quinn, RJ and Abdelmohsen, UR (2019) Potential of marine natural products against drug-resistant bacterial infections. The Lancet Infectious Diseases 19, e237–e245.10.1016/S1473-3099(18)30711-4CrossRefGoogle ScholarPubMed
Liu, J-Y, Jiang, Y-Y, Li, P-J, Yao, B, Song, Y-J, Gao, J-X, Said, G, Gao, Y, Lai, J-Y and Shao, C-L (2024) Discovery of a potential bladder cancer inhibitor CHNQD-01281 by regulating EGFR and promoting infiltration of cytotoxic T cells. Marine Life Science & Technology 6, 502–514.10.1007/s42995-024-00246-wCrossRefGoogle ScholarPubMed
Lomartire, S and Gonçalves, AMM (2022) Antiviral activity and mechanisms of seaweeds bioactive compounds on enveloped viruses – a review. Marine Drugs 20, 385.10.3390/md20060385CrossRefGoogle ScholarPubMed
Long, BH, Carboni, JM, Wasserman, AJ, Cornell, LA, Casazza, AM, Jensen, PR, Lindel, T, Fenical, W and Fairchild, CR (1998) Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol®). Cancer Research 58, 1111–1115.Google ScholarPubMed
Look, SA, Fenical, W, Jacobs, RS and Clardy, J (1986) The pseudopterosins: anti-inflammatory and analgesic natural products from the sea whip Pseudopterogorgia elisabethae. Proceedings of the National Academy of Sciences 83, 6238–6240.10.1073/pnas.83.17.6238CrossRefGoogle ScholarPubMed
Lounas, R, Kasmi, H, Chernai, S, Amarni, N, Ghebriout, L, Meslem-Haoui, N and Hamdi, B (2020) Towards sustainable mariculture: some global trends. Thalassas: An International Journal of Marine Sciences 36, 447–456.10.1007/s41208-020-00206-yCrossRefGoogle Scholar
Lu, D-Y, Chang, C-S, Yeh, W-L, Tang, C-H, Cheung, C, Leung, Y-M, Liu, J-F and Wong, K-L (2012) The novel phloroglucinol derivative BFP induces apoptosis of glioma cancer through reactive oxygen species and endoplasmic reticulum stress pathways. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 19, 1093–1100.10.1016/j.phymed.2012.06.010CrossRefGoogle ScholarPubMed
Lv, Y, Song, Q, Shao, Q, Gao, W, Mao, H, Lou, H, Qu, X and Li, X (2012) Comparison of the effects of marchantin C and fucoidan on sFlt-1 and angiogenesis in glioma microenvironment. The Journal of Pharmacy and Pharmacology 64, 604–609.10.1111/j.2042-7158.2011.01430.xCrossRefGoogle ScholarPubMed
Mafi, A, Rahmati, A, Babaei Aghdam, Z, Salami, R, Salami, M, Vakili, O and Aghadavod, E (2022) Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. Cellular & Molecular Biology Letters 27, 1–32.10.1186/s11658-022-00354-4CrossRefGoogle ScholarPubMed
Malve, H (2016) Exploring the ocean for new drug developments: marine pharmacology. Journal of Pharmacy & Bioallied Sciences 8, 83–91.10.4103/0975-7406.171700CrossRefGoogle ScholarPubMed
Mattos, DR, Wan, X, Serrill, JD, Nguyen, MH, Humphreys, IR, Viollet, B, Smith, AB, McPhail, KL and Ishmael, JE (2022) The marine-derived macrolactone mandelalide A is an indirect activator of AMPK. Marine Drugs 20, 418.10.3390/md20070418CrossRefGoogle Scholar
Mazzoleni, A, Awuah, WA, Sanker, V, Bharadwaj, HR, Aderinto, N, Tan, JK, Huang, HYR, Poornaselvan, J, Shah, MH, Atallah, O, Tawfik, A, Elmanzalawi, MEAE, Ghozlan, SH, Abdul-Rahman, T, Moyondafoluwa, JA, Alexiou, A and Papadakis, M (2024) Chromosomal instability: a key driver in glioma pathogenesis and progression. European Journal of Medical Research 29, 1–17.10.1186/s40001-024-02043-8CrossRefGoogle ScholarPubMed
Medema, MH, Blin, K, Cimermancic, P, de Jager, V, Zakrzewski, P, Fischbach, MA, Weber, T, Takano, E and Breitling, R (2011) antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Research 39, W339–W346.10.1093/nar/gkr466CrossRefGoogle ScholarPubMed
Meesil, W, Muangpat, P, Sitthisak, S, Rattanarojpong, T, Chantratita, N, Machado, RAR, Shi, Y-M, Bode, HB, Vitta, A and Thanwisai, A (2023) Genome mining reveals novel biosynthetic gene clusters in entomopathogenic bacteria. Scientific Reports 13, 20764.10.1038/s41598-023-47121-9CrossRefGoogle ScholarPubMed
Méresse, S, Fodil, M, Fleury, F and Chénais, B (2020) Fucoxanthin, a marine-derived carotenoid from brown seaweeds and microalgae: a promising bioactive compound for cancer therapy. International Journal of Molecular Sciences 21, 9273.10.3390/ijms21239273CrossRefGoogle ScholarPubMed
Miljanich, GP (2004) Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Current Medicinal Chemistry 11, 3029–3040.10.2174/0929867043363884CrossRefGoogle ScholarPubMed
Miri, MR, Zare, A, Saberzadeh, J, Baghban, N, Nabipour, I and Tamadon, A (2022) Anti-lung cancer marine compounds: a review. Therapeutic Innovation & Regulatory Science 56, 191–205.10.1007/s43441-022-00375-3CrossRefGoogle ScholarPubMed
Mizrachi, A, Shamay, Y, Shah, J, Brook, S, Soong, J, Rajasekhar, VK, Humm, JL, Healey, JH, Powell, SN, Baselga, J, Heller, DA, Haimovitz-Friedman, A and Scaltriti, M (2017) Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma. Nature Communications 8, 14292.10.1038/ncomms14292CrossRefGoogle ScholarPubMed
Molinski, TF, Dalisay, DS, Lievens, SL and Saludes, JP (2009) Drug development from marine natural products. Nature Reviews Drug Discovery 8, 69–85.10.1038/nrd2487CrossRefGoogle ScholarPubMed
Montuori, E, Capalbo, A and Lauritano, C (2022) Marine compounds for melanoma treatment and prevention. International Journal of Molecular Sciences 23, 10284.10.3390/ijms231810284CrossRefGoogle ScholarPubMed
Montuori, E, Hyde, CAC, Crea, F, Golding, J and Lauritano, C (2023) Marine natural products with activities against prostate cancer: recent discoveries. International Journal of Molecular Sciences 24, 1435.10.3390/ijms24021435CrossRefGoogle ScholarPubMed
Mushtaq, S, Abbasi, BH, Uzair, B and Abbasi, R (2018) Natural products as reservoirs of novel therapeutic agents. EXCLI Journal 17, 420–451.Google ScholarPubMed
Nandi, S, Khatua, S, Nag, A, Sen, S, Chakraborty, N, Naskar, A, Acharya, K, Mekky, RH, Contreras, MDM, Calina, D, Dini, I and Sharifi-Rad, J (2024) Dolastatins and their analogues present a compelling landscape of potential natural and synthetic anticancer drug candidates. Current Research in Biotechnology 7, 100167.10.1016/j.crbiot.2023.100167CrossRefGoogle Scholar
Nanjing Agricultural University (2015) Novel Sea Asparagus Triterpenoid Saponin Reducing Compound as Well as Preparation Method and Application Thereof. Nanjing Agricultural University. https://patents.google.com/patent/CN103304622B/zhGoogle Scholar
Neupane, RP, Parrish, SM, Bhandari Neupane, J, Yoshida, WY, Yip, MLR, Turkson, J, Harper, MK, Head, JD and Williams, PG (2019) Cytotoxic sesquiterpenoid quinones and quinols, and an 11-membered heterocycle, kauamide, from the Hawaiian marine sponge Dactylospongia elegans. Marine Drugs 17, 423.10.3390/md17070423CrossRefGoogle Scholar
Nezir, AE, Khalily, MP, Gulyuz, S, Ozcubukcu, S, Küçükgüzel, ŞG, Yilmaz, O and Telci, D (2021) Synthesis and evaluation of tumor-homing peptides for targeting prostate cancer. Amino Acids 53, 645–652.10.1007/s00726-021-02971-3CrossRefGoogle ScholarPubMed
Ningbo University (2014) Angiotensin-Converting Enzyme Inhibition Peptide Sourcing from Marine Microalgae. Ningbo University. https://patents.google.com/patent/CN103923177A/zhGoogle Scholar
Nowak, B, Rogujski, P, Janowski, M, Lukomska, B and Andrzejewska, A (2021) Mesenchymal stem cells in glioblastoma therapy and progression: how one cell does it all. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer 1876, 188582.10.1016/j.bbcan.2021.188582CrossRefGoogle Scholar
Ortega, V and Cortés, J (2012) Potential clinical applications of halichondrins in breast cancer and other neoplasms. Breast Cancer: Targets and Therapy 4, 9–19.Google ScholarPubMed
Papon, N, Copp, BR and Courdavault, V (2022) Marine drugs: biology, pipelines, current and future prospects for production. Biotechnology Advances 54, 107871.10.1016/j.biotechadv.2021.107871CrossRefGoogle ScholarPubMed
Peng, X, Zhang, S, Wang, Y, Zhou, Z, Yu, Z, Zhong, Z, Zhang, L, Chen, Z-S, Claret, FX, Elkabets, M, Wang, F, Sun, F, Wang, R, Liang, H, Lin, H-W and Kong, D (2023) Stellettin B sensitizes glioblastoma to DNA-damaging treatments by suppressing PI3K-mediated homologous recombination repair. Advanced Science 10, 2205529.10.1002/advs.202205529CrossRefGoogle ScholarPubMed
Pereira, F (2019) Have marine natural product drug discovery efforts been productive and how can we improve their efficiency? Expert Opinion on Drug Discovery 14, 717–722.10.1080/17460441.2019.1604675CrossRefGoogle ScholarPubMed
Pereira, RB, Evdokimov, NM, Lefranc, F, Valentão, P, Kornienko, A, Pereira, DM, Andrade, PB and Gomes, NGM (2019) Marine-derived anticancer agents: clinical benefits, innovative mechanisms, and new targets. Marine Drugs 17, 329.10.3390/md17060329CrossRefGoogle ScholarPubMed
Petersen, L-E, Kellermann, MY and Schupp, PJ (2020) Secondary metabolites of marine microbes: from natural products chemistry to chemical ecology. In Simon, J, Viola, L and Maya, B-D (eds), YOUMARES 9 – The Oceans: Our Research, Our Future: Proceedings of the 2018 Conference for Young Marine Researcher in Oldenburg, Germany. Cham: Springer International Publishing, pp. 159–180.10.1007/978-3-030-20389-4_8CrossRefGoogle Scholar
Pettit, G, Kamano, Y, Herald, CL, Fujii, Y, Kizu, H, Boyd, MR, Boettner, FE, Doubek, DL, Schmidt, JM, Chapuis, J and Michel, C (1993) Isolation of dolastatins 10–15 from the marine mollusc Dolabella auricularia. Tetrahedron 49, 9151–9170.10.1016/0040-4020(93)80003-CCrossRefGoogle Scholar
Peugniez, C, Cousin, S and Penel, N (2016) Trabectedin is an effective second-line treatment in soft tissue sarcoma patients. Annals of Oncology 27, 551–552.10.1093/annonc/mdv585CrossRefGoogle Scholar
Porta, EOJ and Steel, PG (2023) Activity-based protein profiling: a graphical review. Current Research in Pharmacology and Drug Discovery 5, 100164.10.1016/j.crphar.2023.100164CrossRefGoogle ScholarPubMed
Potts, BC, Albitar, MX, Anderson, KC, Baritaki, S, Berkers, C, Bonavida, B, Chandra, J, Chauhan, D, Cusack, JC, Fenical, W, Ghobrial, IM, Groll, M, Jensen, PR, Lam, KS, Lloyd, GK, McBride, W, McConkey, DJ, Miller, CP, Neuteboom, STC, Oki, Y, Ovaa, H, Pajonk, F, Richardson, PG, Roccaro, AM, Sloss, CM, Spear, MA, Valashi, E, Younes, A and Palladino, MA (2011) Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Current Cancer Drug Targets 11, 254–284.10.2174/156800911794519716CrossRefGoogle Scholar
Potts, BC and Lam, KS (2010) Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide A (marizomib) and other salinosporamides. Marine Drugs 8, 835–880.10.3390/md8040835CrossRefGoogle ScholarPubMed
Precilla, S, Kuduvalli, S, Praveena, E, Thangavel, S and Anitha, TS (2022) Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma – an in vitro and in vivo perspective. Life Sciences 301, 120609.10.1016/j.lfs.2022.120609CrossRefGoogle Scholar
Qingdao Xin Xin Marine Biotechnology Co Ltd (2017) Prevent and Treat the Ocean Oligopeptides and its Preparation Technology of Postmenopausal Osteoporosis. Qingdao Xin Xin Marine Biotechnology Co Ltd. https://patents.google.com/patent/CN106854242A/enGoogle Scholar
Quang, TH, Lee, D-S, Han, SJ, Kim, IC, Yim, JH, Kim, Y-C and Oh, H (2014) Steroids from the cold water starfish Ctenodiscus crispatus with cytotoxic and apoptotic effects on human hepatocellular carcinoma and glioblastoma cells. Bulletin of the Korean Chemical Society 35, 2335–2341.10.5012/bkcs.2014.35.8.2335CrossRefGoogle Scholar
Raghuvanshi, R and Bharate, SB (2020) Preclinical and clinical studies on bryostatins, a class of marine-derived protein kinase C modulators: a mini-review. Current Topics in Medicinal Chemistry 20, 1124–1135.10.2174/1568026620666200325110444CrossRefGoogle ScholarPubMed
Raies, A, Tulodziecka, E, Stainer, J, Middleton, L, Dhindsa, RS, Hill, P, Engkvist, O, Harper, AR, Petrovski, S and Vitsios, D (2022) DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets. Communications Biology 5, 1–16.10.1038/s42003-022-04245-4CrossRefGoogle Scholar
Reed, KA, Manam, RR, Mitchell, SS, Xu, J, Teisan, S, Chao, T-H, Deyanat-Yazdi, G, Neuteboom, STC, Lam, KS and Potts, BCM (2007) Salinosporamides D–J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome. Journal of Natural Products 70, 269–276.10.1021/np0603471CrossRefGoogle ScholarPubMed
Remington, SJ (2011) Green fluorescent protein: a perspective. Protein Science: A Publication of the Protein Society 20, 1509–1519.10.1002/pro.684CrossRefGoogle ScholarPubMed
Rl, S, An, G and A, Jemal (2024) Cancer statistics, 2024. CA: A Cancer Journal for Clinicians 74, 12–49.Google Scholar
Rogers, AD, Appiah-Madson, H, Ardron, JA, Bax, NJ, Bhadury, P, Brandt, A, Buttigieg, P-L, De Clerck, O, Delgado, C, Distel, DL, Glover, A, Gobin, J, Guilhon, M, Hampton, S, Harden-Davies, H, Hebert, P, Hynes, L, Lowe, M, MacIntyre, S, Madduppa, H, Mazzuco, ADA, McCallum, A, McOwen, C, Nattkemper, TW, Odido, M, O'Hara, T, Osborn, K, Pouponneau, A, Provoost, P, Rabone, M, Ramirez-Llodra, E, Scott, L, Sink, KJ, Turk, D, Watanabe, HK, Weatherdon, LV, Wernberg, T, Williams, S, Woodall, L, Wright, DJ, Zeppilli, D and Steeds, O (2023) Accelerating ocean species discovery and laying the foundations for the future of marine biodiversity research and monitoring. Frontiers in Marine Science 10, 2023.10.3389/fmars.2023.1224471CrossRefGoogle Scholar
Roth, P, Gorlia, T, Reijneveld, JC, de Vos, F, Idbaih, A, Frenel, J-S, Le Rhun, E, Sepulveda, JM, Perry, J, Masucci, GL, Freres, P, Hirte, H, Seidel, C, Walenkamp, A, Lukacova, S, Meijnders, P, Blais, A, Ducray, F, Verschaeve, V, Nicholas, G, Balana, C, Bota, DA, Preusser, M, Nuyens, S, Dhermain, F, van den Bent, M, O'Callaghan, CJ, Vanlancker, M, Mason, W and Weller, M (2024) Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial. Neuro-Oncology 26, 1670–1682.10.1093/neuonc/noae053CrossRefGoogle ScholarPubMed
Saeed, AFUH, Su, J and Ouyang, S (2021) Marine-derived drugs: recent advances in cancer therapy and immune signaling. Biomedicine & Pharmacotherapy 134, 111091.10.1016/j.biopha.2020.111091CrossRefGoogle ScholarPubMed
Sagar, S, Kaur, M and Minneman, KP (2010) Antiviral lead compounds from marine sponges. Marine Drugs 8, 2619–2638.10.3390/md8102619CrossRefGoogle ScholarPubMed
Santos, JD, Vitorino, I, Reyes, F, Vicente, F and Lage, OM (2020) From ocean to medicine: pharmaceutical applications of metabolites from marine bacteria. Antibiotics 9, 455.10.3390/antibiotics9080455CrossRefGoogle ScholarPubMed
Saraswat, S and Chugh, A (2024) Engraulisin: a novel marine derived cell penetrating peptide with activity against drug resistant bacteria. Biochimica et Biophysica Acta (BBA) – Biomembranes 1866, 184255.10.1016/j.bbamem.2023.184255CrossRefGoogle ScholarPubMed
Sathishkumar, K, Chaturvedi, M, Das, P, Stephen, S and Mathur, P (2022) Cancer incidence estimates for 2022 & projection for 2025: result from national cancer registry programme, India. The Indian Journal of Medical Research 156, 598–607.10.4103/ijmr.ijmr_1821_22CrossRefGoogle Scholar
Schöffski, P, Wolter, P, Clement, P, Sciot, R, De Wever, I, Wozniak, A, Stefan, C and Dumez, H (2007) Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma. Future Oncology 3, 381–392.10.2217/14796694.3.4.381CrossRefGoogle ScholarPubMed
Schyschka, L, Rudy, A, Jeremias, I, Barth, N, Pettit, GR and Vollmar, AM (2008) Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP. Leukemia 22, 1737–1745.10.1038/leu.2008.146CrossRefGoogle ScholarPubMed
Scotto, KW (2002) ET-743: more than an innovative mechanism of action. Anti-Cancer Drugs 13, S3–S6.Google ScholarPubMed
Serrill, JD, Wan, X, Hau, AM, Jang, HS, Coleman, DJ, Indra, AK, Alani, AWG, McPhail, KL and Ishmael, JE (2016) Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts. Investigational New Drugs 34, 24–40.10.1007/s10637-015-0303-xCrossRefGoogle ScholarPubMed
Shanghai Changzheng Hospital (2012) Dimeric Sesquiterpene Compound Hippolide I, Its Preparation Method and Its Purpose. Shanghai Changzheng Hospital. https://patents.google.com/patent/CN102617526A/enGoogle Scholar
Shergalis, A, Bankhead, A, Luesakul, U, Muangsin, N and Neamati, N (2018) Current challenges and opportunities in treating glioblastoma. Pharmacological Reviews 70, 412–445.10.1124/pr.117.014944CrossRefGoogle ScholarPubMed
Shinde, P, Banerjee, P and Mandhare, A (2019) Marine natural products as source of new drugs: a patent review (2015–2018). Expert Opinion on Therapeutic Patents 29, 283–309.10.1080/13543776.2019.1598972CrossRefGoogle ScholarPubMed
Simone, M, Erba, E, Damia, G, Vikhanskaya, F, Di Francesco, AM, Riccardi, R, Bailly, C, Cuevas, C, Fernandez Sousa-Faro, JM and D'Incalci, M (2005) Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity. European Journal of Cancer 41, 2366–2377.10.1016/j.ejca.2005.05.015CrossRefGoogle ScholarPubMed
Singh, B and Kumar, A (2024) Advances in microplastics detection: a comprehensive review of methodologies and their effectiveness. TrAC Trends in Analytical Chemistry 170, 117440.10.1016/j.trac.2023.117440CrossRefGoogle Scholar
Ślusarczyk, J, Adamska, E and Czerwik-Marcinkowska, J (2021) Fungi and algae as sources of medicinal and other biologically active compounds: a review. Nutrients 13, 3178.10.3390/nu13093178CrossRefGoogle ScholarPubMed
Song, T, Chen, M, Chai, W, Zhang, Z and Lian, X-Y (2018) New bioactive pyrrospirones C–I from a marine-derived fungus Penicillium sp. ZZ380. Tetrahedron 74, 884–891.10.1016/j.tet.2018.01.015CrossRefGoogle Scholar
South China Sea Institute of Oceanology of CAS (2013 a) Phenazine Compound and it Application in Preparation of Anti-Tumor Drugs. South China Sea Institute of Oceanology of CAS. https://patents.google.com/patent/CN103360329B/enGoogle Scholar
South China Sea Institute of Oceanology of CAS (2013 b) Sulfur-Containing Diindolyl Diketopiperazine Compounds and Application Thereof in Preparing Antineoplastic Drugs. South China Sea Institute of Oceanology of CAS. https://patents.google.com/patent/CN102911188B/enGoogle Scholar
South China Sea Institute of Oceanology of CAS (2017) Strepsesquitriol, preparation method thereof, and application thereof. US Patent 9701603B2.Google Scholar
Spradlin, JN, Zhang, E and Nomura, DK (2021) Reimagining druggability using chemoproteomic platforms. Accounts of Chemical Research 54, 1801–1813.10.1021/acs.accounts.1c00065CrossRefGoogle ScholarPubMed
Staats, PS, Yearwood, T, Charapata, SG, Presley, RW, Wallace, MS, Byas-Smith, M, Fisher, R, Bryce, DA, Mangieri, EA, Luther, RR, Mayo, M, McGuire, D and Ellis, D (2004) Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDSA randomized controlled trial. JAMA 291, 63–70.10.1001/jama.291.1.63CrossRefGoogle ScholarPubMed
Sun Yat Sen University (2013) Sesterterpine Compounds, and Preparation Method and Application Thereof. Sun Yat Sen University. https://patents.google.com/patent/CN102936252A/enGoogle Scholar
Tabudravu, JN, Eijsink, VGH, Gooday, GW, Jaspars, M, Komander, D, Legg, M, Synstad, B and van Aalten, DMF (2002) Psammaplin A, a chitinase inhibitor isolated from the Fijian marine sponge Aplysinella rhax. Bioorganic & Medicinal Chemistry 10, 1123–1128.10.1016/S0968-0896(01)00372-8CrossRefGoogle ScholarPubMed
Tabunoki, H, Saito, N, Suwanborirux, K, Charupant, K and Satoh, J (2012) Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids. Cancer Cell International 12, 14.10.1186/1475-2867-12-14CrossRefGoogle ScholarPubMed
Tan, LT and Phyo, MY (2020) Marine cyanobacteria: a source of lead compounds and their clinically-relevant molecular targets. Molecules 25, 2197.10.3390/molecules25092197CrossRefGoogle ScholarPubMed
Tardi, P, Johnstone, S, Harasym, N, Xie, S, Harasym, T, Zisman, N, Harvie, P, Bermudes, D and Mayer, L (2009) In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. Leukemia Research 33, 129–139.10.1016/j.leukres.2008.06.028CrossRefGoogle ScholarPubMed
Thomas, TRA, Kavlekar, DP and LokaBharathi, PA (2010) Marine drugs from sponge-microbe association – a review. Marine Drugs 8, 1417–1468.10.3390/md8041417CrossRefGoogle ScholarPubMed
Tian, L-W, Feng, Y, Shimizu, Y, Pfeifer, T, Wellington, C, Hooper, JNA and Quinn, RJ (2014) Aplysinellamides A–C, bromotyrosine-derived metabolites from an Australian Aplysinella sp. marine sponge. Journal of Natural Products 77, 1210–1214.10.1021/np500119eCrossRefGoogle ScholarPubMed
Tobeiha, M, Rajabi, A, Raisi, A, Mohajeri, M, Yazdi, SM, Davoodvandi, A, Aslanbeigi, F, Vaziri, M, Hamblin, MR and Mirzaei, H (2021) Potential of natural products in osteosarcoma treatment: focus on molecular mechanisms. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 144, 112257.10.1016/j.biopha.2021.112257CrossRefGoogle ScholarPubMed
Trisciuoglio, D, Uranchimeg B, and Cardellina, JH (2008) Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide. JNCI: Journal of the National Cancer Institute 100, 1233–1246, Available at https://academic.oup.com/jnci/article/100/17/1233/905718 (accessed 5 August 2024).10.1093/jnci/djn239CrossRefGoogle Scholar
Tseng, C-C, Lai, Y-C, Kuo, T-J, Su, J-H, Sung, P-J, Feng, C-W, Lin, Y-Y, Chen, P-C, Tai, M-H, Cheng, S-Y, Kuo, H-M and Wen, Z-H (2019) Rhodoptilometrin, a crinoid-derived anthraquinone, induces cell regeneration by promoting wound healing and oxidative phosphorylation in human gingival fibroblast cells. Marine Drugs 17, 138.10.3390/md17030138CrossRefGoogle ScholarPubMed
Tsuji, S, Nakamura, S, Maoka, T, Yamada, T, Imai, T, Ohba, T, Yako, T, Hayashi, M, Endo, K, Saio, M, Hara, H and Shimazawa, M (2020) Antitumour effects of astaxanthin and adonixanthin on glioblastoma. Marine Drugs 18, 474.10.3390/md18090474CrossRefGoogle ScholarPubMed
Van Soest, RWM, Boury-Esnault, N, Vacelet, J, Dohrmann, M, Erpenbeck, D, De Voogd, NJ, Santodomingo, N, Vanhoorne, B, Kelly, M and Hooper, JNA (2012) Global diversity of sponges (Porifera). PLoS One 7, e35105.10.1371/journal.pone.0035105CrossRefGoogle ScholarPubMed
Varterasian, ML, Mohammad, RM, Shurafa, MS, Hulburd, K, Pemberton, PA, Rodriguez, DH, Spadoni, V, Eilender, DS, Murgo, A, Wall, N, Dan, M and Al-Katib, AM (2000) Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Clinical Cancer Research 6, 825–828.Google ScholarPubMed
Wang, Y, Habgood, GJ, Christ, WJ, Kishi, Y, Littlefield, BA and Yu, MJ (2000) Structure–activity relationships of halichondrin B analogues: modifications at C.30–C.38. Bioorganic & Medicinal Chemistry Letters 10, 1029–1032.10.1016/S0960-894X(00)00150-5CrossRefGoogle Scholar
Warabi, K, Matsunaga, S, van Soest, RWM and Fusetani, N (2003) Dictyodendrins A–E, the first telomerase-inhibitory marine natural products from the sponge Dictyodendrilla verongiformis. The Journal of Organic Chemistry 68, 2765–2770.10.1021/jo0267910CrossRefGoogle ScholarPubMed
Waseda University (2017) Marine Organism-Derived Extract, Compound, and Medical Composition Having Niche Formation Suppressing Activity of Leukemic Stem Cells. Waseda University. https://patents.google.com/patent/WO2017122736A1/enGoogle Scholar
Wätjen, W, Ebada, SS, Bergermann, A, Chovolou, Y, Totzke, F, Kubbutat, MHG, Lin, W and Proksch, P (2017) Cytotoxic effects of the anthraquinone derivatives 1′-deoxyrhodoptilometrin and (S)-(−)-rhodoptilometrin isolated from the marine echinoderm Comanthus sp. Archives of Toxicology 91, 1485–1495.10.1007/s00204-016-1787-7CrossRefGoogle ScholarPubMed
Wei, F, Wang, S and Gou, X (2021) A review for cell-based screening methods in drug discovery. Biophysics Reports 7, 504–516.Google ScholarPubMed
Weller, M, Wen, PY, Chang, SM, Dirven, L, Lim, M, Monje, M and Reifenberger, G (2024) Glioma. Nature Reviews. Disease Primers 10, 33.10.1038/s41572-024-00516-yCrossRefGoogle ScholarPubMed
Wen, Z-H, Kuo, H-M, Shih, P-C, Hsu, L-C, Chuang, JM-J, Chen, N-F, Sun, H-W, Liu, H-T, Sung, C-S and Chen, W-F (2023) Isoaaptamine increases ROS levels causing autophagy and mitochondria-mediated apoptosis in glioblastoma multiforme cells. Biomedicine & Pharmacotherapy 160, 114359.10.1016/j.biopha.2023.114359CrossRefGoogle ScholarPubMed
Williams, PG, Yoshida, WY, Moore, RE and Paul, VJ (2002) Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp. Journal of Natural Products 65, 1336–1339.10.1021/np020184qCrossRefGoogle ScholarPubMed
Wu, Y-J, Huang, T-Y, Huang, C-Y, Lin, C-C, Wang, W-L, Huang, H-C, Liu, S-YV, Chao, C-H and Sheu, J-H (2023) Anti-inflammatory halogenated monoterpenes from the red alga Portieria hornemannii. Marine Drugs 21, 493.10.3390/md21090493CrossRefGoogle ScholarPubMed
Xiamen University (2015) Cyclic Dipeptides in Marine Streptomyces sp. and Preparation Method Thereof. Xiamen University. https://patents.google.com/patent/CN105199989A/enGoogle Scholar
Xiao, H, Zhao, J, Fang, C, Cao, Q, Xing, M, Li, X, Hou, J, Ji, A and Song, S (2020) Advances in studies on the pharmacological activities of fucoxanthin. Marine Drugs 18, 634.10.3390/md18120634CrossRefGoogle ScholarPubMed
Xin, W, Ye, X, Yu, S, Lian, X-Y and Zhang, Z (2012) New capoamycin-type antibiotics and polyene acids from marine Streptomyces fradiae PTZ0025. Marine Drugs 10, 2388–2402.10.3390/md10112388CrossRefGoogle ScholarPubMed
Xining Yige Intellectual Property Advisory Services Co Ltd (2015) New Sesquiterpene Quinine Compound in Dysidea avara and Application Thereof. Xining Yige Intellectual Property Advisory Services Co Ltd. https://patents.google.com/patent/CN104478688A/enGoogle Scholar
Xue, Y, Fu, Y, Zhao, F, Gui, G, Li, Y, Rivero-Hinojosa, S, Liu, G, Li, Y, Xia, S, Eberhart, CG and Ying, M (2021) Frondoside A inhibits an MYC-driven medulloblastoma model derived from human-induced pluripotent stem cells. Molecular Cancer Therapeutics 20, 1199–1209.10.1158/1535-7163.MCT-20-0603CrossRefGoogle ScholarPubMed
Yan, H, Parsons, DW, Jin, G, McLendon, R, Rasheed, BA, Yuan, W, Kos, I, Batinic-Haberle, I, Jones, S, Riggins, GJ, Friedman, H, Friedman, A, Reardon, D, Herndon, J, Kinzler, KW, Velculescu, VE, Vogelstein, B and Bigner, DD (2009) IDH1 and IDH2 mutations in gliomas. The New England Journal of Medicine 360, 765–773.10.1056/NEJMoa0808710CrossRefGoogle ScholarPubMed
Yao, Y, Sun, S, Cao, M, Mao, M, He, J, Gai, Q, Qin, Y, Yao, X, Lu, H, Chen, F, Wang, W, Luo, M, Zhang, H, Huang, H, Ju, J, Bian, X-W and Wang, Y (2020) Grincamycin B functions as a potent inhibitor for glioblastoma stem cell via targeting RHOA and PI3K/AKT. ACS Chemical Neuroscience 11, 2256–2265.10.1021/acschemneuro.0c00206CrossRefGoogle ScholarPubMed
Yasuhara, M, Cronin, TM, deMenocal, PB, Okahashi, H and Linsley, BK (2008) Abrupt climate change and collapse of deep-sea ecosystems. Proceedings of the National Academy of Sciences 105, 1556–1560.10.1073/pnas.0705486105CrossRefGoogle ScholarPubMed
Ye, X, Anjum, K, Song, T, Wang, W, Liang, Y, Chen, M, Huang, H, Lian, X-Y and Zhang, Z (2017) Antiproliferative cyclodepsipeptides from the marine actinomycete Streptomyces sp. P11–23B downregulating the tumor metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis. Phytochemistry 135, 151–159.10.1016/j.phytochem.2016.12.010CrossRefGoogle ScholarPubMed
Yellow Sea Fisheries Research Institute Chinese Academy of Fishery Sciences (2015) Marine Bacillus Polypeptide and Preparation and Application Thereof. Yellow Sea Fisheries Research Institute Chinese Academy of Fishery Sciences.Google Scholar
Youssef, DTA, Almagthali, H, Shaala, LA and Schmidt, EW (2020) Secondary metabolites of the genus Didemnum: a comprehensive review of chemical diversity and pharmacological properties. Marine Drugs 18, 307.10.3390/md18060307CrossRefGoogle ScholarPubMed
Yu, S, Ye, X, Huang, H, Peng, R, Su, Z, Lian, X-Y and Zhang, Z (2015) Bioactive sulfated saponins from sea cucumber Holothuria moebii. Planta Medica 81, 152–159.Google ScholarPubMed
Zaibaq, F, Dowdy, T and Larion, M (2022) Targeting the sphingolipid rheostat in gliomas. International Journal of Molecular Sciences 23, 9255.10.3390/ijms23169255CrossRefGoogle ScholarPubMed
Zhang, X, Ye, X, Chai, W, Lian, X-Y and Zhang, Z (2016) New metabolites and bioactive actinomycins from marine-derived Streptomyces sp. ZZ338. Marine Drugs 14, 181.10.3390/md14100181CrossRefGoogle ScholarPubMed
Zhang, D, Yi, W, Ge, H, Zhang, Z and Wu, B (2019) Bioactive streptoglutarimides A–J from the marine-derived Streptomyces sp. ZZ741. Journal of Natural Products 82, 2800–2808.10.1021/acs.jnatprod.9b00481CrossRefGoogle ScholarPubMed
Zhang, F, Zhao, M, Braun, DR, Ericksen, SS, Piotrowski, JS, Nelson, J, Peng, J, Ananiev, GE, Chanana, S, Barns, K, Fossen, J, Sanchez, H, Chevrette, MG, Guzei, IA, Zhao, C, Guo, L, Tang, W, Currie, CR, Rajski, SR, Audhya, A, Andes, DR and Bugni, TS (2020) A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science 370, 974–978.10.1126/science.abd6919CrossRefGoogle ScholarPubMed
Zhejiang Meixin Holding Co., Ltd. (2017) Compound with BRD4 Inhibitory Activity and Its Preparation Method and Application. Zhejiang Meixin Holding Co., Ltd.. https://patents.google.com/patent/CN106883113A/enGoogle Scholar
Zhejiang University ZJU (2020) Preparation and Medical Application of Streptomyces xanthioides Acid and Streptomyces xanthione. Zhejiang University ZJU. https://patents.google.com/patent/CN110627640A/enGoogle Scholar
Zhu, Q, Zhou, Y, Wang, H, Cao, T, Wang, X, Liu, R, Wu, H and Lin, B (2023) Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor. Medical Oncology 40, 1–13.10.1007/s12032-023-02095-6CrossRefGoogle ScholarPubMed